Stay updated with breaking news from Anne Berman. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Immuneering Co. (NASDAQ:IMRX – Get Rating) was the target of a large growth in short interest in March. As of March 31st, there was short interest totalling 1,930,000 shares, a growth of 43.0% from the March 15th total of 1,350,000 shares. Approximately 10.1% of the company’s stock are short sold. Based on an average trading […]
Zacks Investment Research cut shares of Immuneering (NASDAQ:IMRX – Get Rating) from a buy rating to a hold rating in a research note issued to investors on Monday morning, Zacks.com reports. According to Zacks, “Immuneering Corporation is a biopharmaceutical company advancing a pipeline of oncology and neuroscience product candidates. The company’s product candidate includes IMM-1-104. […]